nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.121	0.171	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0803	0.114	CbGbCtD
Iloperidone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0803	0.114	CbGbCtD
Iloperidone—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0776	0.11	CbGbCtD
Iloperidone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0621	0.0879	CbGbCtD
Iloperidone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0603	0.0852	CbGbCtD
Iloperidone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0471	0.0666	CbGbCtD
Iloperidone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0404	0.0571	CbGbCtD
Iloperidone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0399	0.0564	CbGbCtD
Iloperidone—CYP3A4—Prednisone—ankylosing spondylitis	0.0376	0.0532	CbGbCtD
Iloperidone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.037	0.0523	CbGbCtD
Iloperidone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0235	0.0332	CbGbCtD
Iloperidone—Mania—Dexamethasone—ankylosing spondylitis	0.00266	0.00908	CcSEcCtD
Iloperidone—Mania—Betamethasone—ankylosing spondylitis	0.00266	0.00908	CcSEcCtD
Iloperidone—Hypothyroidism—Prednisone—ankylosing spondylitis	0.00263	0.00896	CcSEcCtD
Iloperidone—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.00242	0.00826	CcSEcCtD
Iloperidone—Delusion—Prednisone—ankylosing spondylitis	0.00238	0.00813	CcSEcCtD
Iloperidone—Mania—Prednisone—ankylosing spondylitis	0.00232	0.00791	CcSEcCtD
Iloperidone—Cataract—Triamcinolone—ankylosing spondylitis	0.00224	0.00765	CcSEcCtD
Iloperidone—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.0022	0.00752	CcSEcCtD
Iloperidone—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.0022	0.00752	CcSEcCtD
Iloperidone—Fluid retention—Prednisolone—ankylosing spondylitis	0.0022	0.00751	CcSEcCtD
Iloperidone—Endocrine disorder—Prednisone—ankylosing spondylitis	0.00203	0.00694	CcSEcCtD
Iloperidone—Cataract—Dexamethasone—ankylosing spondylitis	0.00203	0.00694	CcSEcCtD
Iloperidone—Cataract—Betamethasone—ankylosing spondylitis	0.00203	0.00694	CcSEcCtD
Iloperidone—Fluid retention—Triamcinolone—ankylosing spondylitis	0.00203	0.00691	CcSEcCtD
Iloperidone—Fluid retention—Methylprednisolone—ankylosing spondylitis	0.00202	0.00689	CcSEcCtD
Iloperidone—Delirium—Prednisone—ankylosing spondylitis	0.00196	0.00669	CcSEcCtD
Iloperidone—Amenorrhoea—Prednisone—ankylosing spondylitis	0.00192	0.00655	CcSEcCtD
Iloperidone—Fluid retention—Betamethasone—ankylosing spondylitis	0.00184	0.00627	CcSEcCtD
Iloperidone—Fluid retention—Dexamethasone—ankylosing spondylitis	0.00184	0.00627	CcSEcCtD
Iloperidone—Increased appetite—Prednisolone—ankylosing spondylitis	0.00179	0.00611	CcSEcCtD
Iloperidone—Dry eye—Betamethasone—ankylosing spondylitis	0.00179	0.0061	CcSEcCtD
Iloperidone—Dry eye—Dexamethasone—ankylosing spondylitis	0.00179	0.0061	CcSEcCtD
Iloperidone—Cataract—Prednisone—ankylosing spondylitis	0.00177	0.00604	CcSEcCtD
Iloperidone—Affect lability—Prednisolone—ankylosing spondylitis	0.00166	0.00565	CcSEcCtD
Iloperidone—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00165	0.00562	CcSEcCtD
Iloperidone—Amnesia—Methylprednisolone—ankylosing spondylitis	0.00164	0.00561	CcSEcCtD
Iloperidone—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.00164	0.00561	CcSEcCtD
Iloperidone—Fluid retention—Prednisone—ankylosing spondylitis	0.0016	0.00546	CcSEcCtD
Iloperidone—Mood swings—Prednisolone—ankylosing spondylitis	0.0016	0.00544	CcSEcCtD
Iloperidone—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00158	0.0054	CcSEcCtD
Iloperidone—Musculoskeletal stiffness—Methotrexate—ankylosing spondylitis	0.00157	0.00536	CcSEcCtD
Iloperidone—Affect lability—Triamcinolone—ankylosing spondylitis	0.00152	0.0052	CcSEcCtD
Iloperidone—Affect lability—Methylprednisolone—ankylosing spondylitis	0.00152	0.00519	CcSEcCtD
Iloperidone—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00151	0.00515	CcSEcCtD
Iloperidone—Increased appetite—Betamethasone—ankylosing spondylitis	0.0015	0.0051	CcSEcCtD
Iloperidone—Increased appetite—Dexamethasone—ankylosing spondylitis	0.0015	0.0051	CcSEcCtD
Iloperidone—Mood swings—Triamcinolone—ankylosing spondylitis	0.00147	0.005	CcSEcCtD
Iloperidone—Mood swings—Methylprednisolone—ankylosing spondylitis	0.00146	0.00499	CcSEcCtD
Iloperidone—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00144	0.00491	CcSEcCtD
Iloperidone—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00144	0.00491	CcSEcCtD
Iloperidone—Lethargy—Betamethasone—ankylosing spondylitis	0.00143	0.00489	CcSEcCtD
Iloperidone—Lethargy—Dexamethasone—ankylosing spondylitis	0.00143	0.00489	CcSEcCtD
Iloperidone—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.0014	0.00476	CcSEcCtD
Iloperidone—Affect lability—Dexamethasone—ankylosing spondylitis	0.00138	0.00472	CcSEcCtD
Iloperidone—Affect lability—Betamethasone—ankylosing spondylitis	0.00138	0.00472	CcSEcCtD
Iloperidone—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00137	0.00468	CcSEcCtD
Iloperidone—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00137	0.00468	CcSEcCtD
Iloperidone—Asthma—Triamcinolone—ankylosing spondylitis	0.00134	0.00457	CcSEcCtD
Iloperidone—Mood swings—Dexamethasone—ankylosing spondylitis	0.00133	0.00454	CcSEcCtD
Iloperidone—Mood swings—Betamethasone—ankylosing spondylitis	0.00133	0.00454	CcSEcCtD
Iloperidone—Weight increased—Prednisolone—ankylosing spondylitis	0.00132	0.00452	CcSEcCtD
Iloperidone—Amnesia—Prednisone—ankylosing spondylitis	0.0013	0.00444	CcSEcCtD
Iloperidone—Increased appetite—Prednisone—ankylosing spondylitis	0.0013	0.00444	CcSEcCtD
Iloperidone—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00128	0.00436	CcSEcCtD
Iloperidone—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00128	0.00436	CcSEcCtD
Iloperidone—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.00127	0.00435	CcSEcCtD
Iloperidone—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00126	0.0043	CcSEcCtD
Iloperidone—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00126	0.0043	CcSEcCtD
Iloperidone—Cardiac failure—Prednisone—ankylosing spondylitis	0.00125	0.00428	CcSEcCtD
Iloperidone—Lethargy—Prednisone—ankylosing spondylitis	0.00125	0.00426	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00124	0.00424	CcSEcCtD
Iloperidone—Weight increased—Triamcinolone—ankylosing spondylitis	0.00122	0.00416	CcSEcCtD
Iloperidone—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00122	0.00415	CcSEcCtD
Iloperidone—Affect lability—Prednisone—ankylosing spondylitis	0.0012	0.00411	CcSEcCtD
Iloperidone—Psychotic disorder—Prednisone—ankylosing spondylitis	0.0012	0.00408	CcSEcCtD
Iloperidone—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00116	0.00396	CcSEcCtD
Iloperidone—Mood swings—Prednisone—ankylosing spondylitis	0.00116	0.00395	CcSEcCtD
Iloperidone—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00113	0.00384	CcSEcCtD
Iloperidone—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00111	0.0038	CcSEcCtD
Iloperidone—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00111	0.00378	CcSEcCtD
Iloperidone—Weight increased—Dexamethasone—ankylosing spondylitis	0.00111	0.00377	CcSEcCtD
Iloperidone—Weight increased—Betamethasone—ankylosing spondylitis	0.00111	0.00377	CcSEcCtD
Iloperidone—Weight decreased—Dexamethasone—ankylosing spondylitis	0.0011	0.00375	CcSEcCtD
Iloperidone—Weight decreased—Betamethasone—ankylosing spondylitis	0.0011	0.00375	CcSEcCtD
Iloperidone—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00105	0.00359	CcSEcCtD
Iloperidone—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00105	0.00359	CcSEcCtD
Iloperidone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00105	0.00358	CcSEcCtD
Iloperidone—Lethargy—Methotrexate—ankylosing spondylitis	0.00104	0.00356	CcSEcCtD
Iloperidone—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00104	0.00355	CcSEcCtD
Iloperidone—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000999	0.00341	CcSEcCtD
Iloperidone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000992	0.00338	CcSEcCtD
Iloperidone—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000974	0.00332	CcSEcCtD
Iloperidone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00097	0.00331	CcSEcCtD
Iloperidone—Mood swings—Methotrexate—ankylosing spondylitis	0.000969	0.00331	CcSEcCtD
Iloperidone—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000963	0.00329	CcSEcCtD
Iloperidone—Weight increased—Prednisone—ankylosing spondylitis	0.000962	0.00328	CcSEcCtD
Iloperidone—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000957	0.00326	CcSEcCtD
Iloperidone—Weight decreased—Prednisone—ankylosing spondylitis	0.000957	0.00326	CcSEcCtD
Iloperidone—Vision blurred—Prednisolone—ankylosing spondylitis	0.000956	0.00326	CcSEcCtD
Iloperidone—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000955	0.00326	CcSEcCtD
Iloperidone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000936	0.00319	CcSEcCtD
Iloperidone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00093	0.00317	CcSEcCtD
Iloperidone—Breast disorder—Methotrexate—ankylosing spondylitis	0.000924	0.00315	CcSEcCtD
Iloperidone—Vertigo—Prednisolone—ankylosing spondylitis	0.000911	0.00311	CcSEcCtD
Iloperidone—Eye disorder—Betamethasone—ankylosing spondylitis	0.000908	0.0031	CcSEcCtD
Iloperidone—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000908	0.0031	CcSEcCtD
Iloperidone—Asthma—Methotrexate—ankylosing spondylitis	0.000884	0.00302	CcSEcCtD
Iloperidone—Angiopathy—Betamethasone—ankylosing spondylitis	0.000882	0.00301	CcSEcCtD
Iloperidone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000882	0.00301	CcSEcCtD
Iloperidone—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000868	0.00296	CcSEcCtD
Iloperidone—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000868	0.00296	CcSEcCtD
Iloperidone—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000847	0.00289	CcSEcCtD
Iloperidone—Vertigo—Triamcinolone—ankylosing spondylitis	0.000838	0.00286	CcSEcCtD
Iloperidone—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000836	0.00285	CcSEcCtD
Iloperidone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000832	0.00284	CcSEcCtD
Iloperidone—Oedema—Prednisolone—ankylosing spondylitis	0.000828	0.00282	CcSEcCtD
Iloperidone—Dysuria—Methotrexate—ankylosing spondylitis	0.000826	0.00282	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000821	0.0028	CcSEcCtD
Iloperidone—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000814	0.00278	CcSEcCtD
Iloperidone—Tachycardia—Prednisolone—ankylosing spondylitis	0.000808	0.00276	CcSEcCtD
Iloperidone—Myalgia—Triamcinolone—ankylosing spondylitis	0.000794	0.00271	CcSEcCtD
Iloperidone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000792	0.0027	CcSEcCtD
Iloperidone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000792	0.0027	CcSEcCtD
Iloperidone—Eye disorder—Prednisone—ankylosing spondylitis	0.000791	0.0027	CcSEcCtD
Iloperidone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000776	0.00265	CcSEcCtD
Iloperidone—Stomatitis—Methotrexate—ankylosing spondylitis	0.000768	0.00262	CcSEcCtD
Iloperidone—Angiopathy—Prednisone—ankylosing spondylitis	0.000768	0.00262	CcSEcCtD
Iloperidone—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000766	0.00261	CcSEcCtD
Iloperidone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000766	0.00261	CcSEcCtD
Iloperidone—Oedema—Triamcinolone—ankylosing spondylitis	0.000761	0.0026	CcSEcCtD
Iloperidone—Vertigo—Dexamethasone—ankylosing spondylitis	0.00076	0.00259	CcSEcCtD
Iloperidone—Vertigo—Betamethasone—ankylosing spondylitis	0.00076	0.00259	CcSEcCtD
Iloperidone—Arrhythmia—Prednisone—ankylosing spondylitis	0.000756	0.00258	CcSEcCtD
Iloperidone—Infection—Triamcinolone—ankylosing spondylitis	0.000756	0.00258	CcSEcCtD
Iloperidone—Infection—Methylprednisolone—ankylosing spondylitis	0.000754	0.00257	CcSEcCtD
Iloperidone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000745	0.00254	CcSEcCtD
Iloperidone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000745	0.00254	CcSEcCtD
Iloperidone—Epistaxis—Methotrexate—ankylosing spondylitis	0.000743	0.00254	CcSEcCtD
Iloperidone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000743	0.00254	CcSEcCtD
Iloperidone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000743	0.00253	CcSEcCtD
Iloperidone—Mental disorder—Prednisone—ankylosing spondylitis	0.000742	0.00253	CcSEcCtD
Iloperidone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000741	0.00253	CcSEcCtD
Iloperidone—Malnutrition—Prednisone—ankylosing spondylitis	0.000737	0.00251	CcSEcCtD
Iloperidone—Myalgia—Betamethasone—ankylosing spondylitis	0.00072	0.00246	CcSEcCtD
Iloperidone—Myalgia—Dexamethasone—ankylosing spondylitis	0.00072	0.00246	CcSEcCtD
Iloperidone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00071	0.00242	CcSEcCtD
Iloperidone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000699	0.00238	CcSEcCtD
Iloperidone—Vision blurred—Prednisone—ankylosing spondylitis	0.000694	0.00237	CcSEcCtD
Iloperidone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000693	0.00237	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000693	0.00237	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000692	0.00236	CcSEcCtD
Iloperidone—Oedema—Betamethasone—ankylosing spondylitis	0.000691	0.00236	CcSEcCtD
Iloperidone—Oedema—Dexamethasone—ankylosing spondylitis	0.000691	0.00236	CcSEcCtD
Iloperidone—Infection—Dexamethasone—ankylosing spondylitis	0.000686	0.00234	CcSEcCtD
Iloperidone—Infection—Betamethasone—ankylosing spondylitis	0.000686	0.00234	CcSEcCtD
Iloperidone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000683	0.00233	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000682	0.00233	CcSEcCtD
Iloperidone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000682	0.00233	CcSEcCtD
Iloperidone—Anaemia—Prednisone—ankylosing spondylitis	0.000681	0.00232	CcSEcCtD
Iloperidone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000679	0.00231	CcSEcCtD
Iloperidone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000677	0.00231	CcSEcCtD
Iloperidone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000677	0.00231	CcSEcCtD
Iloperidone—Agitation—Prednisone—ankylosing spondylitis	0.000677	0.00231	CcSEcCtD
Iloperidone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000674	0.0023	CcSEcCtD
Iloperidone—Tachycardia—Betamethasone—ankylosing spondylitis	0.000674	0.0023	CcSEcCtD
Iloperidone—Vertigo—Prednisone—ankylosing spondylitis	0.000662	0.00226	CcSEcCtD
Iloperidone—Eye disorder—Methotrexate—ankylosing spondylitis	0.000661	0.00226	CcSEcCtD
Iloperidone—Tinnitus—Methotrexate—ankylosing spondylitis	0.00066	0.00225	CcSEcCtD
Iloperidone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000657	0.00224	CcSEcCtD
Iloperidone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000656	0.00224	CcSEcCtD
Iloperidone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000655	0.00223	CcSEcCtD
Iloperidone—Hypotension—Dexamethasone—ankylosing spondylitis	0.000645	0.0022	CcSEcCtD
Iloperidone—Hypotension—Betamethasone—ankylosing spondylitis	0.000645	0.0022	CcSEcCtD
Iloperidone—Angiopathy—Methotrexate—ankylosing spondylitis	0.000642	0.00219	CcSEcCtD
Iloperidone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000638	0.00218	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000629	0.00215	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000629	0.00215	CcSEcCtD
Iloperidone—Arthralgia—Prednisone—ankylosing spondylitis	0.000627	0.00214	CcSEcCtD
Iloperidone—Myalgia—Prednisone—ankylosing spondylitis	0.000627	0.00214	CcSEcCtD
Iloperidone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000627	0.00214	CcSEcCtD
Iloperidone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000626	0.00213	CcSEcCtD
Iloperidone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00062	0.00212	CcSEcCtD
Iloperidone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00062	0.00212	CcSEcCtD
Iloperidone—Mental disorder—Methotrexate—ankylosing spondylitis	0.00062	0.00211	CcSEcCtD
Iloperidone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000616	0.0021	CcSEcCtD
Iloperidone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000602	0.00205	CcSEcCtD
Iloperidone—Oedema—Prednisone—ankylosing spondylitis	0.000601	0.00205	CcSEcCtD
Iloperidone—Infection—Prednisone—ankylosing spondylitis	0.000597	0.00204	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000596	0.00203	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000596	0.00203	CcSEcCtD
Iloperidone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000595	0.00203	CcSEcCtD
Iloperidone—Fatigue—Betamethasone—ankylosing spondylitis	0.000595	0.00203	CcSEcCtD
Iloperidone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00059	0.00201	CcSEcCtD
Iloperidone—Tachycardia—Prednisone—ankylosing spondylitis	0.000587	0.002	CcSEcCtD
Iloperidone—Vision blurred—Methotrexate—ankylosing spondylitis	0.00058	0.00198	CcSEcCtD
Iloperidone—Anaemia—Methotrexate—ankylosing spondylitis	0.000569	0.00194	CcSEcCtD
Iloperidone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000569	0.00194	CcSEcCtD
Iloperidone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000569	0.00194	CcSEcCtD
Iloperidone—Vertigo—Methotrexate—ankylosing spondylitis	0.000553	0.00189	CcSEcCtD
Iloperidone—Leukopenia—Methotrexate—ankylosing spondylitis	0.000551	0.00188	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000548	0.00187	CcSEcCtD
Iloperidone—Dizziness—Prednisolone—ankylosing spondylitis	0.000547	0.00187	CcSEcCtD
Iloperidone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000546	0.00186	CcSEcCtD
Iloperidone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000546	0.00186	CcSEcCtD
Iloperidone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000546	0.00186	CcSEcCtD
Iloperidone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000545	0.00186	CcSEcCtD
Iloperidone—Paraesthesia—Prednisone—ankylosing spondylitis	0.00054	0.00184	CcSEcCtD
Iloperidone—Myalgia—Methotrexate—ankylosing spondylitis	0.000524	0.00179	CcSEcCtD
Iloperidone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000524	0.00179	CcSEcCtD
Iloperidone—Rash—Prednisolone—ankylosing spondylitis	0.000522	0.00178	CcSEcCtD
Iloperidone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000521	0.00178	CcSEcCtD
Iloperidone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00052	0.00177	CcSEcCtD
Iloperidone—Fatigue—Prednisone—ankylosing spondylitis	0.000518	0.00177	CcSEcCtD
Iloperidone—Confusional state—Methotrexate—ankylosing spondylitis	0.000507	0.00173	CcSEcCtD
Iloperidone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000503	0.00172	CcSEcCtD
Iloperidone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000502	0.00171	CcSEcCtD
Iloperidone—Infection—Methotrexate—ankylosing spondylitis	0.000499	0.0017	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000496	0.00169	CcSEcCtD
Iloperidone—Asthenia—Betamethasone—ankylosing spondylitis	0.000495	0.00169	CcSEcCtD
Iloperidone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000495	0.00169	CcSEcCtD
Iloperidone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000493	0.00168	CcSEcCtD
Iloperidone—Nausea—Prednisolone—ankylosing spondylitis	0.000492	0.00168	CcSEcCtD
Iloperidone—Rash—Triamcinolone—ankylosing spondylitis	0.00048	0.00164	CcSEcCtD
Iloperidone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000479	0.00164	CcSEcCtD
Iloperidone—Rash—Methylprednisolone—ankylosing spondylitis	0.000479	0.00163	CcSEcCtD
Iloperidone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000478	0.00163	CcSEcCtD
Iloperidone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000475	0.00162	CcSEcCtD
Iloperidone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000472	0.00161	CcSEcCtD
Iloperidone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000472	0.00161	CcSEcCtD
Iloperidone—Hypotension—Methotrexate—ankylosing spondylitis	0.00047	0.0016	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000458	0.00156	CcSEcCtD
Iloperidone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000457	0.00156	CcSEcCtD
Iloperidone—Dizziness—Betamethasone—ankylosing spondylitis	0.000457	0.00156	CcSEcCtD
Iloperidone—Nausea—Triamcinolone—ankylosing spondylitis	0.000452	0.00154	CcSEcCtD
Iloperidone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000451	0.00154	CcSEcCtD
Iloperidone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000451	0.00154	CcSEcCtD
Iloperidone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000448	0.00153	CcSEcCtD
Iloperidone—Somnolence—Methotrexate—ankylosing spondylitis	0.000447	0.00152	CcSEcCtD
Iloperidone—Rash—Dexamethasone—ankylosing spondylitis	0.000435	0.00149	CcSEcCtD
Iloperidone—Rash—Betamethasone—ankylosing spondylitis	0.000435	0.00149	CcSEcCtD
Iloperidone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000435	0.00148	CcSEcCtD
Iloperidone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000435	0.00148	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000434	0.00148	CcSEcCtD
Iloperidone—Fatigue—Methotrexate—ankylosing spondylitis	0.000433	0.00148	CcSEcCtD
Iloperidone—Asthenia—Prednisone—ankylosing spondylitis	0.000431	0.00147	CcSEcCtD
Iloperidone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000414	0.00141	CcSEcCtD
Iloperidone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000411	0.0014	CcSEcCtD
Iloperidone—Nausea—Dexamethasone—ankylosing spondylitis	0.00041	0.0014	CcSEcCtD
Iloperidone—Nausea—Betamethasone—ankylosing spondylitis	0.00041	0.0014	CcSEcCtD
Iloperidone—Dizziness—Prednisone—ankylosing spondylitis	0.000398	0.00136	CcSEcCtD
Iloperidone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000397	0.00136	CcSEcCtD
Iloperidone—Rash—Prednisone—ankylosing spondylitis	0.000379	0.00129	CcSEcCtD
Iloperidone—Dermatitis—Prednisone—ankylosing spondylitis	0.000379	0.00129	CcSEcCtD
Iloperidone—Asthenia—Methotrexate—ankylosing spondylitis	0.000361	0.00123	CcSEcCtD
Iloperidone—Nausea—Prednisone—ankylosing spondylitis	0.000357	0.00122	CcSEcCtD
Iloperidone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000344	0.00117	CcSEcCtD
Iloperidone—Dizziness—Methotrexate—ankylosing spondylitis	0.000332	0.00113	CcSEcCtD
Iloperidone—Rash—Methotrexate—ankylosing spondylitis	0.000317	0.00108	CcSEcCtD
Iloperidone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000317	0.00108	CcSEcCtD
Iloperidone—Nausea—Methotrexate—ankylosing spondylitis	0.000299	0.00102	CcSEcCtD
